LYMPHDX
Live / Allowed — Notice of allowance issued (as of 16 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99191737
- Mark type
- Stylized text
- Filed
- 19 May 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Kimberly B. Herman
Goods and services
- Class 001 — Chemicals: Assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and medical diagnostics or screening kits comprised of reagents for medical diagnostics or screening use; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes
- Class 010 — Medical apparatus: Testing instruments for medical diagnostic purposes, namely, apparatus for the analysis of body fluids, tissue samples and liquid biopsies
- Class 042 — Scientific and technological services: Scientific and medical research services; providing an online database in the field of genetics and cancer for medical or scientific research; providing temporary use of on-line non-downloadable software and applications for use in studying, diagnosing or screening for cancer and studying genetics and DNA; providing temporary use of on-line non-downloadable cloud computing software for use in studying, diagnosing or screening cancer and studying genetics and DNA; providing temporary use of on-line non-downloadable software and applications for use in studying, diagnosing or screening for cancer; providing temporary use of on-line non-downloadable cloud computing software for use in studying, diagnosing or screening cancer; Software as a Service (SaaS) services featuring software in the nature of a platform for genetic and bioinformatics analysis
- Class 044 — Medical, beauty and agricultural services: Genetic testing and reporting for medical purposes; medical testing for diagnostic or treatment purposes; medical screening; medical diagnostic testing, monitoring and reporting services; providing a website featuring medical information regarding genetics; genetic analysis and reporting services for medical purposes
Owner
- Droplet Biosciences, Inc., Cambridge, MA, US
- Droplet Biosciences, Inc., Cambridge, MA, US
Prosecution history
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Sept 2025 — ASSIGNED TO EXAMINER
- 19 May 2025 — APPLICATION FILING RECEIPT MAILED
- 19 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 May 2025 — NEW APPLICATION ENTERED